Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Thomas O Cole

Biographic Data

ID2788880
NAMEThomas O Cole
GIVEN NAMESThomas
FAMILY NAMEO Cole
SIGNATURECOLE T O
AFFILIATIONSUniversity of Maryland, Baltimore
ORCID0000-0003-4238-7939
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
AUTHOR COUNT5
EDITOR COUNT0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2024
H-INDEX0
  • On the Value of Measuring Recent Drug Use by Self-Reports and Urinalysis in Clinical Trials

    ERIC D WISH, Amy S Billing et al.•ARTICLE•Substance Use & Misuse•2024

    Background: Valid measurement of drug use in patients enrolled in clinical trials that treat substance use disorder is vital to determine the trial’s outcome. Self-reports are often used but their validity has been studied with mixed results. Urinalysis may sometimes be employed as an alternative or supplement to self-reports. Objectives: This study examined how estimating drug use by either method would affect the results from a randomized clini…

  • Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder

    Open Access•John M Clifton, John Clifton et al.•ARTICLE•Journal of Psychedelic Studies•2022•References: 41

    Background and aims There is growing evidence that psilocybin, a serotonergic psychedelic substance, may be useful in the treatment of substance use disorders. However, there is a lack of data on the beliefs and attitudes towards psilocybin amongst Black individuals diagnosed with Opioid Use Disorder (OUD). This study characterized psilocybin use patterns and perception of risk amongst a cohort of Black individuals diagnosed with OUD. Methods Usi…

  • Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine

    Open Access•Thomas O Cole, Darlene Robinson et al.•ARTICLE•Frontiers in Public Health•2021

    Telemedicine is increasingly being used to treat patients with opioid use disorder (OUD). It has particular value in rural areas of the United States impacted by the opioid crisis as these areas have a shortage of trained addiction medicine providers. Patient satisfaction significantly impacts positive clinical outcomes in OUD treatment and thus is of great clinical interest. Yet little is known regarding patient satisfaction with the increasingl…

  • Buprenorphine Induction in a Rural Maryland Detention Center During Covid-19

    Open Access•Annabelle M Belcher, Kelly Coble et al.•ARTICLE•Frontiers in Psychiatry•2021

    Over 10 million individuals pass through U.S. detention centers on an annual basis, with nearly two-thirds meeting criteria for drug dependence/abuse. Despite proven efficacy, treatment with medications for opioid use disorder (MOUD) is underutilized in jail settings-a gap that could be addressed using telemedicine. Here we describe a new program of telemedicine-based clinical provision of new/continuing buprenorphine treatment for individuals de…

  • Race-based differences in drug use prior to onset of opioid use disorder

    Open Access•Sasha Deutsch‐Link, Annabelle M Belcher et al.•ARTICLE•Journal of Ethnicity in Substance…•2021

    Rates of opioid use disorder (OUD) have increased dramatically over the past two decades, a rise that has been accompanied by changing demographics of those affected. Early exposure to drugs is a known risk factor for later development of opioid use disorder; but how and whether this risk factor may differ between racial groups is unknown. Our study seeks to identify race differences in self-report of current and past substance use in OUD-diagnos…

No prominent works on this page.

  • Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine

    Open Access•Thomas O Cole, Darlene Robinson et al.•ARTICLE•Frontiers in Public Health•2021

    Telemedicine is increasingly being used to treat patients with opioid use disorder (OUD). It has particular value in rural areas of the United States impacted by the opioid crisis as these areas have a shortage of trained addiction medicine providers. Patient satisfaction significantly impacts positive clinical outcomes in OUD treatment and thus is of great clinical interest. Yet little is known regarding patient satisfaction with the increasingl…

  • Buprenorphine Induction in a Rural Maryland Detention Center During Covid-19

    Open Access•Annabelle M Belcher, Kelly Coble et al.•ARTICLE•Frontiers in Psychiatry•2021

    Over 10 million individuals pass through U.S. detention centers on an annual basis, with nearly two-thirds meeting criteria for drug dependence/abuse. Despite proven efficacy, treatment with medications for opioid use disorder (MOUD) is underutilized in jail settings-a gap that could be addressed using telemedicine. Here we describe a new program of telemedicine-based clinical provision of new/continuing buprenorphine treatment for individuals de…

  • Race-based differences in drug use prior to onset of opioid use disorder

    Open Access•Sasha Deutsch‐Link, Annabelle M Belcher et al.•ARTICLE•Journal of Ethnicity in Substance…•2021

    Rates of opioid use disorder (OUD) have increased dramatically over the past two decades, a rise that has been accompanied by changing demographics of those affected. Early exposure to drugs is a known risk factor for later development of opioid use disorder; but how and whether this risk factor may differ between racial groups is unknown. Our study seeks to identify race differences in self-report of current and past substance use in OUD-diagnos…

  • Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder

    Open Access•John M Clifton, John Clifton et al.•ARTICLE•Journal of Psychedelic Studies•2022•References: 41

    Background and aims There is growing evidence that psilocybin, a serotonergic psychedelic substance, may be useful in the treatment of substance use disorders. However, there is a lack of data on the beliefs and attitudes towards psilocybin amongst Black individuals diagnosed with Opioid Use Disorder (OUD). This study characterized psilocybin use patterns and perception of risk amongst a cohort of Black individuals diagnosed with OUD. Methods Usi…

  • On the Value of Measuring Recent Drug Use by Self-Reports and Urinalysis in Clinical Trials

    ERIC D WISH, Amy S Billing et al.•ARTICLE•Substance Use & Misuse•2024

    Background: Valid measurement of drug use in patients enrolled in clinical trials that treat substance use disorder is vital to determine the trial’s outcome. Self-reports are often used but their validity has been studied with mixed results. Urinalysis may sometimes be employed as an alternative or supplement to self-reports. Objectives: This study examined how estimating drug use by either method would affect the results from a randomized clini…

Medicine (5 works) · Internal Medicine (4 works) · Opioid (4 works) · Opioid use disorder (4 works) · Psychiatry (4 works) · Opioid Use Disorder Treatment (3 works) · Substance Abuse Treatment and Outcomes (3 works) · Buprenorphine (2 works) · Forensic Toxicology and Drug Analysis (2 works) · Health care (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae